Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12)
Document Type
- Journal article (12)
Language
- English (12) (remove)
Keywords
- scleroderma (3)
- Autologous hematopoietic stem cell transplantation (2)
- B cells (2)
- Systemic sclerosis (2)
- cytokines (2)
- giant cell arteritis (2)
- inflammation (2)
- polymyalgia rheumatica (2)
- rheumatoid arthritis (2)
- systemic sclerosis (2)
- B cell culture (1)
- CMV reactivation (1)
- Coronavirus Disease 2019 (1)
- GCA (1)
- Grave’s disease (1)
- Infectious complications (1)
- Interleukin-10 (1)
- Memory B cells (1)
- PHQ-9 (1)
- PMR (1)
- PRO (1)
- PU.1 (1)
- S100A8/S100A9 (1)
- SF-36 (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Sjögren’s syndrome (1)
- Th17 (1)
- Th9 (1)
- VAS (1)
- [18F]FDG PET/CT (1)
- acute respiratory distress syndrome (1)
- adverse events (1)
- autoimmune disease (1)
- autoimmune encephalitis (1)
- autoimmunity (1)
- autologous hematopoietic stem cell transplantation (1)
- autologous stem cell transplantation (1)
- c-reactive protein (1)
- calprotectin (1)
- common variable immunodeficiency (1)
- common variable immunodeficiency (CVID) (1)
- depression (1)
- engraftment syndrome (1)
- fever (1)
- genital warts (1)
- growth differentiation factor 15 (1)
- human papillomavirus (1)
- immune response (1)
- immunophenotyping (1)
- immunosuppression (1)
- inborn errors of immunity (IEIs) (1)
- inflammation marker (1)
- interleukin-9 (1)
- memory B cells (1)
- mental impairment (1)
- modified Rodnan skin score (mRSS) (1)
- mycophenolate (1)
- naïve B cells (1)
- primary immunodeficiencies (1)
- primary immunodeficiency (1)
- risk factor analysis (1)
- rituximab (1)
- tocilizumab (1)
- vasculature (1)
- vasculitis (1)
- γδ T cells (1)
Institute
- Medizinische Klinik und Poliklinik II (12)
- Frauenklinik und Poliklinik (2)
- Kinderklinik und Poliklinik (2)
- Medizinische Klinik und Poliklinik I (2)
- Institut für Psychologie (1)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
Objectives
The severity of Coronavirus Disease 2019 (COVID-19) is largely determined by the immune response. First studies indicate altered lymphocyte counts and function. However, interactions of pro- and anti-inflammatory mechanisms remain elusive. In the current study we characterized the immune responses in patients suffering from severe COVID-19-induced acute respiratory distress syndrome (ARDS).
Methods
This was a single-center retrospective study in patients admitted to the intensive care unit (ICU) with confirmed COVID-19 between March 14th and May 28th 2020 (n = 39). Longitudinal data were collected within routine clinical care, including flow-cytometry of lymphocyte subsets, cytokine analysis and growth differentiation factor 15 (GDF-15). Antibody responses against the receptor binding domain (RBD) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike protein were analyzed.
Results
All patients suffered from severe ARDS, 30.8% died. Interleukin (IL)-6 was massively elevated at every time-point. The anti-inflammatory cytokine IL-10 was concomitantly upregulated with IL-6. The cellular response was characterized by lymphocytopenia with low counts of CD8+ T cells, natural killer (NK) and naïve T helper cells. CD8+ T and NK cells recovered after 8 to 14 days. The B cell system was largely unimpeded. This coincided with a slight increase in anti-SARS-CoV-2-Spike-RBD immunoglobulin (Ig) G and a decrease in anti-SARS-CoV-2-Spike-RBD IgM. GDF-15 levels were elevated throughout ICU treatment.
Conclusions
Massively elevated levels of IL-6 and a delayed cytotoxic immune defense characterized severe COVID-19-induced ARDS. The B cell response and antibody production were largely unimpeded. No obvious imbalance of pro- and anti-inflammatory mechanisms was observed, with elevated GDF-15 levels suggesting increased tissue resilience.
Autologous hematopoietic stem cell transplantation (aHSCT) represents an effective treatment for systemic sclerosis (SSc), but it also can cause immunological adverse events (iAEs). Therefore, we aimed to determine the frequency of iAEs [engraftment syndrome (ES) and secondary autoimmune disorder (sAD)] and to identify potential risk factors for their development in a retrospective analysis on 22 patients similarly transplanted due to SSc. While nine patients (41%) suffered from ESs, seven sADs occurred in six patients (27%). Patients who developed ES were older in our cohort (52.45 vs. 42.58 years, p = .0433, Cohen’s d = 0.86), and cardiac involvement by SSc was associated with development of ES (OR = 40.11, p = .0017). Patients with manifestation of sAD had a higher modified Rodnan skin score (mRSS) reduction after aHSCT (90.50% vs. 60.00%, p = .0064, r = .65). Thus, IAEs are common after aHSCT for SSc and can occur in different stages during and after aHSCT with characteristic clinical manifestations. Good cutaneous response after aHSCT might be considered as a risk factor for sAD, and higher age at aHSCT and cardiac involvement might be considered as risk factors for the development of ES.